Approval · Notice of Compliance 28997 · 2022
MICRO PLUS 4 REGULAR STRENGTH: Notice of Compliance 28997
Issued September 16, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 28997
- Date
- September 16, 2022
- Company
- Sandoz Canada Inc.Saint-Hubert, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Update to the safety information in the package insert
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MICRO PLUS 4 REGULAR STRENGTH | Not yet assigned | — |